Volume 21, Issue 1
Heterocyclic Compounds
Full Access

ChemInform Abstract: Alkyl Substituted 3-PPP Derivatives. Synthesis and Biological Investigation.

H. TECLE

H. TECLE

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
S. C. BERGMEIER

S. C. BERGMEIER

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
L. D. WISE

L. D. WISE

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
F. M. HERSHENSON

F. M. HERSHENSON

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
L. L. COUGHENOUR

L. L. COUGHENOUR

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
T. G. HEFFNER

T. G. HEFFNER

Parke-Davis Pharm. Res. Div., Warner-Lambert Co., Ann Arbor, MI 48105-2430, USA

Search for more papers by this author
First published: January 2, 1990

Abstract

The title compounds (VI), (VII), (XIII), and (XVI) are alkylated derivatives of the known 3-PPP (VIII), a prototype dopamine autoreceptor agonist.

ChemInform Abstract

The title compounds (VI), (VII), (XIII), and (XVI) are alkylated derivatives of the known 3-PPP (VIII), a prototype dopamine autoreceptor agonist. Their synthesis is carried out as shown in the scheme in order to study the effects of substituents on the activity compared to (VIII). None of the compounds prepared are found to be more potent than (VIII). The ethyl derivative (VIb) is obtained similarly to (VIa).

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.